Rod - a question about HumulinR. I understand that the patent has expired but when I googled this I found out the following;-
Generic Humulin R
At this time, there are no generic Humulin R products licensed for sale. Insulin medications are considered "biologic" drugs, which are regulated by certain laws that prevent any generic versions from being manufactured in the United States. Until these laws change, no generic drug companies will be allowed to produce any generic Humulin R products.
Humulin R is made by Hospira, Inc. and is marketed and distributed by Eli Lilly and Company. At this time, there are no generic versions of Humulin R (or any other insulins) available.
Where does this leave HALO? Presumably unless the law changes they will not be able to launch a generic version of HumulinR themselves.
With regard to the expenditure position everything depends on when the Phase 3 trials commence. These will be very expensive - too expensive I would imagine for HALO to carry the costs of more than one of these alone unless they get further deals, milestones, royalties etc.
Market Data 
Markets 
AI
